Does percutaneous transthoracic needle biopsy increase the risk of pleural recurrence in patients with stage I lung cancer?
Cheng D, Wang Z, Cui J, Liu L.
Interact Cardiovasc Thorac Surg. 2020 Jun 1;30(6):834-838. doi: 10.1093/icvts/ivaa027.
PMID:32390049
Tissue Adequacy and Safety of Percutaneous Transthoracic Needle Biopsy for Molecular Analysis in Non-Small Cell Lung Cancer: A Systematic Review and Meta-analysis.
Nam BD, Yoon SH, Hong H, Hwang JH, Goo JM, Park S.
Korean J Radiol. 2021 Dec;22(12):2082-2093. doi: 10.3348/kjr.2021.0244. Epub 2021 Aug 31.
PMID:34564960
Percutaneous Transthoracic Lung Biopsy: Optimizing Yield and Mitigating Risk.
2024 Feb 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
PMID:30020662
The Society for Translational Medicine: indications and methods of percutaneous transthoracic needle biopsy for diagnosis of lung cancer.
Zhou Q, Dong J, He J, Liu D, Tian DH, Gao S, Li S, Liu L, He J, Huang Y, Xu S, Mao W, Tan Q, Chen C, Li X, Zhang Z, Jiang G, Xu L, Zhang L, Fu J, Li H, Wang Q, Tan L, Li D, Zhou Q, Fu X, Jiang Z, Chen H, Fang W, Zhang X, Li Y, Tong T, Yu Z, Liu Y, Zhi X, Yan T, Zhang X, Casal RF, Pompeo E, Carretta A, Riquet M, Rena O, Falcoz PE, Saji H, Khan AZ, Danguilan JL, Gonzalez-Rivas D, Guibert N, Zhu C, Shen J.